Nanoparticles as delivery carriers for anticancer prodrugs. - Wikidata - awgldk - TriplyDB

Nanoparticles as delivery carriers for anticancer prodrugs.

Nanoparticles as delivery carriers for anticancer prodrugs.

http://www.wikidata.org/entity/Q38002956

about

Noninvasive approach for enhancing small interfering RNA delivery percutaneously.Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.Pharmaceutical and biomedical applications of lipid-based nanocarriers.Novel nanoparticulate systems for lung cancer therapy: an updated review.The codrug approach for facilitating drug delivery and bioactivity.Chitosan magnetic nanoparticles for drug delivery systems.Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging.Specific targeting and noninvasive imaging of breast cancer stem cells using single-walled carbon nanotubes as novel multimodality nanoprobes.

P2860

Q35848069-171DB521-E15C-4D63-B72B-03A5F9C9A218 Q36630698-3747CBB6-46C6-4E79-9FEC-854F9E34075F Q38192709-05FB66CB-B3EC-498D-8F88-28311E57C46E Q38762917-84B171A7-55B2-4019-BAA4-65C713410E51 Q38829610-CA1EE455-C48D-48E2-8F52-46E4397FB5DE Q38849973-49FDB0C4-3A0F-4B01-A8FE-D3217132BC6A Q39122521-1E69535E-080D-41F3-B114-D0B4E151468D Q41382500-75E16F4C-0C7D-4601-8279-3B3848F6F362 Q51581869-A0593E95-667F-4D09-9D3E-9A61E5621EC1 Q53242502-5D03D708-22CD-4718-B44F-E8476A7F4E16

P2860

Nanoparticles as delivery carriers for anticancer prodrugs.

http://www.wikidata.org/entity/Q38002956

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nanoparticles as delivery carriers for anticancer prodrugs.

@en

type

label

Nanoparticles as delivery carriers for anticancer prodrugs.

@en

prefLabel

Nanoparticles as delivery carriers for anticancer prodrugs.

@en

P1433

Q38002956-77F90737-40E7-402A-8E16-99EB8CB2A30F

P1476

Q38002956-4307A0C2-5AAB-48DF-B0A4-5CD9B61E7A44

P2093

Q38002956-563702B0-C294-4F57-935D-C18942B4E649

Q38002956-F2789C3A-F32F-419A-9399-91604A77E910

P2860

Q38002956-0146840C-5B6C-4DF9-987C-F6B2C5250AA9

Q38002956-018C33F1-63F7-4204-942A-9AC9FE193437

Q38002956-024CEAF3-CD70-49A2-A0B7-2F43C4CFB5CC

Q38002956-0349973E-988C-4B3D-880D-BBBF18964CC0

Q38002956-05AE07FE-00A5-40DF-BD76-3A56BCDF1725

Q38002956-0C14A12F-4911-4E5E-9B11-90990F0060CC

Q38002956-0EC1DB2C-908F-4133-9FC8-BAF342CD0F32

Q38002956-10FB7D2D-E769-455E-B18C-80ECFA3B3CDD

Q38002956-13AF5F51-E2EB-4607-B26E-6A2944B6096B

Q38002956-14AE6D13-9B3C-4693-B02C-F53B203C5749

P304

Q38002956-4B76FD20-1F11-414B-BE85-B951B93A2254

P31

Q38002956-5AECB12C-74B4-410E-83E4-221DFD4DC84A

P356

Q38002956-5D528F11-0A3D-474E-81D1-DCCF6F83CFB1

P407

Q38002956-CA346915-F0B0-49D1-B101-FD6F6CEA345D

P433

Q38002956-2EA9A9F4-9775-435B-9C14-569997DA113F

P478

Q38002956-36D3580C-B481-4C93-B911-FBA0B6CB6DD8

P577

Q38002956-B0CF96A5-9D7B-4A16-9FA6-F552A936F038

P5875

Q38002956-0CE3588B-E524-480D-9A7B-0AC7F5AB3621

P698

Q38002956-52CA7262-0504-4311-BC76-4EEF105BF7C5

P921

Q38002956-98A28115-A67D-4A91-B47B-5307B67C950A

P356

17425247.2012.679927

P1433

Expert Opinion on Drug Delivery

P1476

Nanoparticles as delivery carriers for anticancer prodrugs.

@en

P2093

Jia-You Fang

http://www.w3.org/2001/XMLSchema#string

Saleh A Al-Suwayeh

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Magnetic nanoparticles for theragnostics

5-ALA for photodynamic photorejuvenation--optimization of treatment regime based on normal-skin fluorescence measurements.

Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.

Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.

Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles

Potential of solid lipid nanoparticles in brain targeting.

Prodrugs--from serendipity to rational design.

Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis

Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.

P304

657-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2012.679927

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224051200

http://www.w3.org/2001/XMLSchema#string

P698

22507134

http://www.w3.org/2001/XMLSchema#string

P921